Fibrocystic breast changes
This disease is one of the common and frequently occurring diseases in women, and is more common in women aged 25 to 45. It is essentially a disorder of the normal structure of the breast caused by physiological hyperplasia and incomplete restoration. In my country, cystic changes are rare, and most of them are glandular hyperplasia, so it is often called "mastopathy". The World Health Organization (WHO) collectively calls it "benign mammary dysplasia". The risk of malignant transformation of this disease is 2 to 4 times higher than that of normal women, and the clinical symptoms and signs are sometimes confused with breast cancer.
-
Site of disease:
breast -
Infectious :
Not contagious -
Frequent population:
More common in women aged 25 to 45 -
Related symptoms:
Mastodynia breast pain breast pain breast lumps cystic breast hyperplasia -
Concurrent disease:
Related Drugs
Ru Zeng Ning Capsules
Manufacturer:
Shaanxi Jianmin Pharmaceutical Co., Ltd.
Rukang Pills
Manufacturer:
Jilin Junhong Pharmaceutical Co., Ltd.
Ru Zeng Ning Tablets
Manufacturer:
Guangdong Sanshun Pharmaceutical Co., Ltd.
Runing Tablets
Manufacturer:
Sichuan Guokang Pharmaceutical Co., Ltd.
Letrozole Tablets
Indication: Treatment of postmenopausal women with advanced breast cancer whose estrogen or progesterone receptors are positive or whose receptor status is unknown and who have undergone natural or induced menopause.
Rukang Capsules
Manufacturer:
China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.
Rukang soft capsule
Manufacturer:
Xi An Daheng Pharmaceutical Co., Ltd.
Related Ingredients
-
D(+)-Trehalose dihydrate list
6138-23-4 -
MYRRH GUM list
9000-45-7 -
OLIBANUM GUM list
8050-07-5 -
Letrozole list
112809-51-5